Table 4

 Selected events in the US postmarketing period: 31 December 2002 to 30 June 2005

AEsReported rates*(E/100 PYs)
*78 522 PYs.
Tuberculosis0.02
Lymphoma0.04
Congestive heart failure0.06
Demyelinating disease0.01
Systemic lupus erythematosus0.03
Opportunistic infections0.06
Blood dyscrasias0.08